The best Bull and Bear pitches based on recency and number of recommendations.
In December this stock nearly doubled after the company issued a PR claiming that the EMA provided them with positive regulatory feedback regarding the proposed phase III trial of ICT-107. I read the PR a few times and I'm not sure whether it… More
ImmunoCellular is yet another dubious outfit that refuses to die after a crushing failure in a clinical trial. The share price bottomed out at 0.72 subsequent to negative results of the phase II trial of ICT-107 in GBM. No statistically significant… More
Read the most recent pitches from players about IMUC.
Recs
zz
Recs
It is going to hit 6 dollars by the end of 2014.
Biotechnology is on the rise.
Recs
according to the company, we can expect results from the ict-107 phase II trail.
Find the members with the highest scoring picks in IMUC.
hendrixharlow (85.40) Score: +452.78
The Score Leader is the player with the highest score across all their picks in IMUC.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
hendrixharlow | 85.40 | 9/22/2011 | 5Y | $688.00 | -99.93% | +352.86% | +452.78 | 0 Comment | ||
Ruckwerts | 21.08 | 9/30/2011 | 3M | $612.00 | -99.92% | +346.66% | +446.58 | 0 Comment | ||
BuffettJunior1 | 99.74 | 9/27/2011 | 5Y | $600.00 | -99.92% | +329.67% | +429.59 | 1 Comment | ||
icrazy | < 20 | 10/21/2011 | 1Y | $560.00 | -99.91% | +314.83% | +414.74 | 0 Comment | ||
mdicksonjr | 89.91 | 11/14/2012 | 5Y | $624.00 | -99.92% | +273.67% | +373.59 | 0 Comment | ||
Schimmyboy | 21.89 | 7/30/2012 | 3Y | $1,296.00 | -99.96% | +269.42% | +369.38 | 0 Comment | ||
brian3305 | < 20 | 10/19/2012 | 1Y | $840.00 | -99.94% | +252.36% | +352.30 | 0 Comment | ||
BigD24359 | < 20 | 11/22/2016 | 5Y | $33.00 | -98.45% | +132.58% | -231.03 | 0 Comment | ||
sk2129 | 30.50 |
|
5Y | $227.52 | -99.78% | +142.26% | -242.03 | 1 Comment | ||
dippinmytoes | 33.70 | 8/5/2014 | 3M | $379.52 | -99.87% | +165.72% | -265.58 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.